NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10811	Companies
234208	Keywords
162977	Articles
125205	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 06/12/2024 at 22:20, 2 years 1 month ago

Nanobiotix hosts virtual discussion on the potential of NBTXR3 in cancer treatments

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual Discussion
PRESS RELEASE

published on 06/12/2024 at 22:15, 2 years 1 month ago

NANOBIOTIX ORGANISE UNE DISCUSSION VIRTUELLE ENTRE EXPERTS SUR LE POTENTIEL DE NBTXR3 EN IMMUNOTHÉRAPIE DANS LE CANCER DE LA TÊTE ET DU COU ET D’AUTRES INDICATIONS LE 18 JUIN 2024
Nanobiotix organise une discussion virtuelle entre experts sur le potentiel de NBTXR3 en immunothérapie dans le cancer de la tête et du cou et d'autres indications le 18 juin 2024

Immunothérapie Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 Discussion Virtuelle
PRESS RELEASE

published on 06/12/2024 at 22:15, 2 years 1 month ago

NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
Nanobiotix to host virtual KOL event discussing NBTXR3 combined with immunotherapy in head and neck cancer and beyond on June 18, 2024

Immunotherapy Head And Neck Cancer NANOBIOTIX NBTXR3 Virtual KOL Event
BRIEF

published on 06/11/2024 at 22:20, 2 years 1 month ago

Nanobiotix : Informations Mensuelles sur les Droits de Vote et Actions

Droits De Vote Euronext Actions Nasdaq NANOBIOTIX
BRIEF

published on 06/11/2024 at 22:20, 2 years 1 month ago

Nanobiotix: Monthly Information on Voting Rights and Shares

Voting Rights Euronext Actions Nasdaq NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 2 years 1 month ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
Publication mensuelle du nombre total de droits de vote et d'actions de Nanobiotix le 31 mai 2024, conformément à la réglementation financière

Communication Financière Droits De Vote Capital Social Biotechnologie NANOBIOTIX
PRESS RELEASE

published on 06/11/2024 at 22:15, 2 years 1 month ago

Voting Rights and Shares Capital of the Company
Nanobiotix discloses its voting rights and shares capital information as of May 31, 2024, in compliance with regulatory requirements. The company is a clinical biotechnology firm listed on Euronext Paris and Nasdaq

Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF

published on 06/02/2024 at 16:05, 2 years 2 months ago

Nanobiotix Announces Promising Data on NBTXR3 for Head and Neck Cancer Patients

Clinical Trial Head And Neck Cancer NANOBIOTIX NBTXR3 ASCO
BRIEF

published on 06/02/2024 at 16:05, 2 years 2 months ago

Nanobiotix annonce des données prometteuses sur NBTXR3 pour les patients atteints d'un cancer de la tête et du cou

Essai Clinique Cancer De La Tête Et Du Cou NANOBIOTIX NBTXR3 ASCO
PRESS RELEASE

published on 06/02/2024 at 16:00, 2 years 2 months ago

Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
Nanobiotix announces new data from Study 1100 showing disease control and tumor response in patients with R/M HNSCC treated with RT-activated NBTXR3 followed by anti-PD-1. Investor event scheduled on June 2nd

NANOBIOTIX Study 1100 R/M HNSCC RT-activated NBTXR3 Anti-PD-1

Accesswire

Published on 08/07/2026 at 14:17, 3 hours 18 minutes ago

NuRAN Wireless Increases Series A Preferred Share Financing to C$7.6 Million and Announces Debt Settlements
Published on 08/07/2026 at 13:00, 4 hours 35 minutes ago

Gold Terra Announces Start of Drilling on the Campbell Shear Northern Zone 103N Extension to Expand 2026 MRE of Inferred 595,000 Ounces, Con Mine, Yellowknife, NWT
Published on 08/07/2026 at 00:45, 16 hours 50 minutes ago

NXT Energy Solutions Announces Second Quarter 2026 Results
Published on 08/06/2026 at 23:15, 18 hours 20 minutes ago

LNG Energy Group Announces Issuance of Second Partial Revocation Order and Further Details on Private Placement Financing
Published on 08/06/2026 at 22:15, 19 hours 20 minutes ago

Biomind Labs Announces Listing on the Canadian Securities Exchange and the Delisting From the Cboe Canada

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 16:51, 44 minutes ago

Issue of Equity
Published on 08/07/2026 at 16:34, 1 hour ago

Net Asset Value(s)
Published on 08/07/2026 at 15:39, 1 hour 56 minutes ago

Predictiv AI Inc. Hires Aktien Media for Internet Advertising Services
Published on 08/07/2026 at 15:16, 2 hours 19 minutes ago

Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
Published on 08/07/2026 at 15:06, 2 hours 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

Les Echos

Published on 08/07/2026 at 15:36, 1 hour 59 minutes ago

NRJ Group - Information relative aux droits de vote au 31.07.2026 (French & English)
Published on 08/07/2026 at 08:30, 9 hours 5 minutes ago

Disclosure of shares outstanding and voting rights - 07.08.2026
Published on 08/07/2026 at 08:30, 9 hours 5 minutes ago

Déclaration nombre d'actions et droits de vote - 07.08.2026
Published on 08/06/2026 at 18:26, 23 hours 9 minutes ago

Air Liquide voting rights as of July 31st 2026
Published on 08/06/2026 at 18:26, 23 hours 9 minutes ago

Air Liquide droits de vote au 31 juillet 2026

View all LES ECHOS COMFI WIRE